T80.311 ABO incompatibility with delayed hemolytic transfusion reaction

Name of the Condition

• ABO incompatibility with delayed hemolytic transfusion reaction.

Summary

This condition describes an immune-mediated adverse reaction that occurs when blood or blood products with incompatible ABO antigens are transfused, leading to delayed hemolysis (destruction of red blood cells). It is a serious complication that can cause systemic effects, including organ damage and hemodynamic instability. The reaction is driven by pre-existing antibodies in the recipient that target antigens on the transfused red blood cells, typically manifesting days to weeks after transfusion.

Causes

ABO incompatibility with delayed hemolytic transfusion reaction results from the transfusion of blood or blood products containing ABO antigens that do not match the recipient's blood type. This mismatch triggers an immune response, where the recipient's antibodies bind to the donor red blood cells, leading to their destruction (hemolysis). The reaction can occur with red blood cells, plasma, or platelets if ABO compatibility is not maintained during transfusion.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Jaundice
• Unexplained anemia
• Elevated bilirubin levels

Diagnosis

Diagnosis involves clinical evaluation of symptoms, laboratory tests to detect hemolysis (e.g., elevated lactate dehydrogenase, decreased haptoglobin, increased indirect bilirubin), and confirmation of ABO incompatibility through blood typing and crossmatching. Transfusion reaction workup, including direct antiglobulin test (DAT) and antibody screening, may be performed to identify the cause.

Treatment Options

Treatment focuses on managing hemolysis and its complications, including supportive care (e.g., hydration, monitoring for renal function), discontinuing the transfusion, and addressing any organ dysfunction. In severe cases, additional interventions such as dialysis or blood product support may be necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of hemolysis and organ involvement. Most patients recover with appropriate treatment, but delayed reactions can lead to significant morbidity if not addressed promptly. Follow-up includes monitoring for recurrence, assessing renal function, and ensuring ABO compatibility in future transfusions.

Complications

• Acute kidney injury
• Disseminated intravascular coagulation (DIC)
• Hypotension or shock
• Multi-organ failure
• Death (in severe cases)

Lifestyle & Prevention

Prevention involves strict adherence to blood typing and crossmatching protocols, verifying blood product compatibility before transfusion, and minimizing errors in labeling or administration. Patients with a history of transfusion reactions should be flagged for careful screening in future transfusions.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, chills, dark urine, or severe pain occur after a transfusion, as these may indicate a delayed hemolytic reaction requiring urgent evaluation and treatment.

Tips for Medical Coders

Document the timing of symptoms (delayed onset), confirmation of ABO incompatibility, and any associated complications. Ensure the code T80.311 is used for delayed hemolytic transfusion reactions specifically, and verify that clinical documentation supports the diagnosis to align with coding guidelines.